Ripple's XRP is down 7% on Friday following bearish pressure from macroeconomic factors, including United States (US) President Donald Trump's tariff threats and rising US inflation. Bitcoin price ...

Bitcoin (BTC) hovers around $82,000 on Monday after falling nearly 15% last week. This price correction triggered a series of liquidations across the crypto market, totaling $687.73 million in the ...

There are definitely things to like about United Therapeutics. With the recent decline, the stock trades at 10.2× forward price-to-earnings (or $308.27 per share). Is now the right time to buy?

United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever United Therapeutics (NASDAQ:UTHR – Get Free Report) last released its quarterly earnings results ...

The biotechnology company reported $6.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.10 by $0.09. United Therapeutics had a return on equity of 19.22% ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the ...

It is also one of the 10 best healthcare stocks for long-term investment. For the full year of 2024, United Therapeutics (NASDAQ:UTHR) reported record revenues of $2.88 billion, reflecting 24% ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief ...